Lithium Ion

Lithium Ion

SCHEMBL31704937

O=C([O-])c1cc(C2CCN(C(=O)C3CC3)CC2)ccn1.[Li+]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ TLR9 Q9NR96 15/20 0.46
▸ TLR8 Q9NR97 15/20 0.46
▸ TLR7 Q9NYK1 15/20 0.46
▸ HTR2B P41595 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ IDE P14735 1/20 0.38
▸ CFTR P13569 1/20 0.38
▸ MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL31706661 1.00 TLR9 (0.46) TLR9TLR8TLR7HTR2BALDH1A1
Lithium Ion SCHEMBL31706258 0.90 TLR9 (0.43) TLR9TLR8TLR7
Lithium Ion SCHEMBL31706750 0.90 TLR9 (0.43) TLR9TLR8TLR7
SCHEMBL31706149 0.87 TLR9 (0.48) TLR9TLR8TLR7HTR2BALDH1A1
SCHEMBL31705266 0.84 TLR8 (0.48) TLR9TLR8TLR7ALDH1A1CFTR
Lithium Ion SCHEMBL21633065 0.83 LNPEP (0.37) ALDH1A1
Lithium Ion SCHEMBL31705981 0.80 TDP1 (0.51) ALDH1A1IDEMAPK1
Lithium Ion SCHEMBL31704941 0.80 TDP1 (0.51) ALDH1A1IDEMAPK1
Lithium Ion SCHEMBL31706495 0.78 TLR9 (0.43) TLR9TLR8TLR7
SCHEMBL31705122 0.78 TLR9 (0.44) TLR9TLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215110-A1 NEW AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS SOS1 INHIBITORS LES LABORATOIRES SERVIER (FR) 2025-10-16 — — WO disclosed
Send feedback